Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> Daklinza GT 3 Approval Update in the EU
Post Info TOPIC: Daklinza GT 3 Approval Update in the EU
dragonfly


Senior Member

Status: Offline
Posts: 395
Date:
RE: Daklinza GT 3 Approval Update in the EU
Permalink  
 

And it works!



__________________
Tig


Admin

Status: Offline
Posts: 9281
Date:
Permalink  
 

Updated Label for Daklinza (daclatasvir) for the 12-week Treatment of Non-cirrhotic Patients with Chronic Hepatitis C Genotype 3 Approved by the European Commission

Daklinza in combination with sofosbuvir is the first 12-week all-oral therapy for genotype 3 patients without cirrhosis in Europe

Hepatitis C genotype 3 progresses faster than genotype 1 and is one of the most difficult-to-treat genotypes

http://hepatitiscnewdrugs.blogspot.com/2015/09/hepatitis-c-genotype-3-updated-label.html



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> Daklinza GT 3 Approval Update in the EU
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.